Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SAIPARENT

SAIPARENT

HealthcarePharmaceuticals & Biotechnology₹2216 cr market cap
₹495.40 ▼ -1.27% today As of 19 Nov 2026
52-week low ₹405.7052-week high ₹623.80

-19.6% from the 52-week high · +23.7% above the low

Sai Parenterals Ltd is a pharmaceutical company engaged in the manufacturing of injectable drugs and formulations. The company focuses on sterile products used in hospitals and clinical settings. Its business model revolves around manufacturing and supplying parenteral medicines to domestic and international markets. Revenue is driven by product sales and contract manufacturing. It emphasizes quality compliance and regulatory standards. The company may also produce generic formulations across therapeutic categories. Growth is supported by rising healthcare demand and export opportunities.

The short version. Return on equity was 2.9% in Mar 2026. Promoter holding was 51.16% in Sep 2026, up 0.00 points over 3 quarters.

1 · The price

How has the stock traded?

SAIPARENT trades 19.6% below its 52-week high and 23.7% above its 52-week low.

Change over period: —

1M+3.9%
3M-7.2%
6M+4.4%
1Y—

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025
Revenue19517919896
Net profit11813-7
Net margin %5.44.46.6-6.9
EPS (₹)2.381.792.98-1.8050287200606914

Annual

FY2026
Revenue381
Net profit14
Net margin %3.7
EPS (₹)3.23

3 · The quality

How well does it turn capital into profit?

Return on equity was 2.9% in Mar 2026; debt to equity is 0.65.

Profitability · 1 years

Returns and margins

Mar 2026
Return on equity %2.9
Return on capital %3.6
EBITDA margin %12.1
Net margin %3.7

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.65
Interest cover1.7x
Current ratio1.44
P/E ratio91.6

4 · The owners

Who holds it, and are they adding?

Promoter holding51.16%

Unchanged over 3 quarters.

Foreign institutions2.85%

Down 2.88 pts over 3 quarters.

Domestic institutions7.84%

Down 5.02 pts over 3 quarters.

Mutual fund schemes4

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Mar 2026Jun 2026Sep 2026Change
Promoter51.1651.1651.160.0
FII5.734.032.85-2.88
DII12.868.537.84-5.02
Public30.2636.2938.15+7.89

Mutual fund holdings · Oct 2026

4 schemes hold this stock

4 the month before.

  • Bandhan Healthcare Fund1.14% of NAV
  • Bandhan Mid Cap Fund0.12% of NAV
  • Motilal Oswal BSE Healthcare ETF0.04% of NAV
  • Bandhan BSE Healthcare Index Fund0.04% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SAIPARENT are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SAIPARENT

What is the SAIPARENT share price?

SAIPARENT (SAIPARENT) last closed at ₹495.40, down 1.27% on the day. Its 52-week range is ₹405.70 to ₹623.80.

What is the market cap of SAIPARENT?

SAIPARENT has a market capitalisation of about ₹2,216 crore. Its price-to-earnings ratio is 91.6.

How are SAIPARENT's latest results?

Return on equity was 2.9% in Mar 2026. Promoter holding was 51.16% in Sep 2026, up 0.00 points over 3 quarters.

Who owns SAIPARENT?

As of Sep 2026, shareholding was: Promoter 51.16%, FII 2.85%, DII 7.84%, Public 38.15%.

How many mutual funds hold SAIPARENT?

4 mutual fund schemes held SAIPARENT in October 2026. That compares with 4 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.